Neuland Laboratories Limited

Bajaj Finserv Mutual Fund increased its stake in Neuland Laboratories from 1.25% to 1.28%, raising its holding by 3,679 shares to 163,632 shares.

A pharmaceutical manufacturer engaged in the production and distribution of bulk drugs, Neuland Labs serves both domestic and international markets through its integrated operations. The company specializes in manufacturing active pharmaceutical ingredients and provides contract manufacturing services to global pharmaceutical companies. Its facilities are designed to meet stringent international quality and regulatory standards for pharmaceutical production.

AMC subsidiary of Bajaj Finserv, India's leading non-banking financial services conglomerate. Launched in 2023 with an aggressive passive-first strategy, offering index funds and ETFs at competitive expense ratios to challenge incumbents in the rapidly growing passive segment. One of the fastest-growing new entrants in the AMC space with strong distribution from Bajaj Finserv's vast financial services network.